RedHill Biopharma Ltd. (RDHL) Form 6-K — Jun 25, 2026
RedHill Biopharma Ltd. has scheduled its Annual General Meeting of Shareholders for July 28, 2026, at its offices in Tel-Aviv, Israel. The accompanying proxy statement solicits votes for the re-appointment of Kesselman & Kesselman as the company's independent auditors for the fiscal year ending December 31, 2026. Shareholders are also asked to re-elect Mr.
Key figures
- Shares Outstanding
- 60809201000
- Record Date
- June 23, 2026
- Meeting Date
- July 28, 2026
- Adss Outstanding
- 6080920
- Quorum Requirement
- 25%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.